Sapphire Star Partners’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-12,290
Closed -$412K 133
2018
Q2
$412K Sell
12,290
-141
-1% -$5.02K 0.43% 83
2018
Q1
$450K Buy
12,431
+1,906
+18% +$66K 0.5% 74
2017
Q4
$335K Buy
+10,525
New +$361K 0.4% 88

Other funds holding LMAT

Sapphire Star Partners's LMAT Position: Q3 2018 in Review

Sapphire Star Partners sold out of LeMaitre Vascular (LMAT) in Q3 2018, closing a stake of 12,290 shares — an estimated $412K sold.

Sapphire Star Partners first reported a position in LMAT in Q4 2017 and held it in 3 quarters. The position peaked at $450K in Q1 2018. 156 funds tracked by Wall St. Rank hold LMAT as of Q3 2018.

  • Sapphire Star Partners reported no remaining LeMaitre Vascular position as of Q3 2018 after selling out during the quarter.
  • Sapphire Star Partners sold 12,290 LeMaitre Vascular shares in Q3 2018, an estimated $412K.
  • Sapphire Star Partners first reported a position in LeMaitre Vascular in Q4 2017 and held it in 3 quarters.
  • Sapphire Star Partners's LeMaitre Vascular position peaked at $450K in Q1 2018.
  • 156 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2018.

Based on Sapphire Star Partners's 13F filing for Q3 2018, filed 8 Nov 2018.